Anti-Influenza A virus HA/Hemagglutinin Reference Antibody (Gedivumab, RUO)
Anti-Influenza A virus HA/Hemagglutinin Reference Antibody (Gedivumab, RUO) 

Anti-Influenza A virus HA/Hemagglutinin Reference Antibody (Gedivumab, RUO)

  • Catalog number: BS10507
  • Availability: In Stock
  • $326.00

  • Ex Tax: $326.00


Available Options

Qty
Description: Gedivumab (BS10507) is a research-grade recombinant antibody targeting HA/Hemagglutinin. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Human
Isotype: IgG1,kappa
Species reactivity: InfluenzaAvirus
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1.4mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: HA/Hemagglutinin
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names: MHAA4549A,RO6876802,RG7745,CAS:1807954-17-1
Background: Hemagglutinin (HA) is a ~63 kDa protein. Binds to sialic acid-containing receptors on the cell surface, bringing about the attachment of the virus particle to the cell. This attachment induces virion internalization either through clathrin-dependent endocytosis or through clathrin- and caveolin-independent pathway. Plays a major role in the determination of host range restriction and virulence. Class I viral fusion protein. Responsible for penetration of the virus into the cell cytoplasm by mediating the fusion of the membrane of the endocytosed virus particle with the endosomal membrane.
Note: For research use only. Not suitable for clinical or therapeutic use.

Images

  • Bioactivity for Anti-Influenza A virus HA/Hemagglutinin Reference Antibody (Gedivumab, RUO)
    Bioactivity

    SEC-HPLC detection for Research Grade Gedivumab.

  • SDS-PAGE for Anti-Influenza A virus HA/Hemagglutinin Reference Antibody (Gedivumab, RUO)
    SDS-PAGE

    SDS-PAGE for Research Grade Gedivumab.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good